Company Filing History:
Years Active: 2015
Title: Bruce Weaver: Innovator in Fusion Protein Technology
Introduction
Bruce Weaver is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has the potential to enhance immune responses, which is crucial in the fight against various diseases.
Latest Patents
Bruce Weaver holds a patent for "Fusion proteins and methods of use." This patent describes compositions that include a fusion protein comprising flagellin and at least one antigen with an isoelectric point greater than about 7.0. The invention focuses on how these proteins can activate Toll-like Receptor 5, which plays a vital role in the immune system. The methods outlined in the patent aim to stimulate a protective immune response by administering a composition that includes an antigen fused to a loop of domain 3 of flagellin.
Career Highlights
Bruce Weaver is currently associated with Vaxinnate Corporation, where he continues to work on innovative solutions in the field of immunology. His expertise in fusion proteins has positioned him as a key player in the development of new therapeutic strategies.
Collaborations
Throughout his career, Bruce has collaborated with talented individuals such as Langzhou Song and Ge Liu. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.
Conclusion
In summary, Bruce Weaver is a distinguished inventor whose work in fusion proteins has the potential to significantly impact immunology. His contributions to the field are marked by his innovative patent and ongoing work at Vaxinnate Corporation.